Therapeutic Area Market Research Reports & Industry Analysis

The Therapeutic Area Market refers to a specific category of diseases or conditions for which there are known medical treatments or promising treatments in development. It is a way to classify drugs without reference to the type of therapy, form of action, or the company that makes it, but instead to look at the disease it treats.

Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.

Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.

...Show More ...Show Less


Therapeutic Area Industry Research & Market Reports

  • Lymphoma Therapeutics

    ... at a CAGR of 6.6% over the analysis period 2023-2030. Non-Hodgkin Lymphoma (NHL) Therapeutics, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$20.5 Billion by the ... Read More

  • Endometriosis Drugs

    ... at a CAGR of 3.0% over the analysis period 2023-2030. Hormone Therapy, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$2.2 Billion by the end of ... Read More

  • Tinea Pedis (Athlete`s Foot) Treatment

    ... is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 3.1% over the analysis period 2023-2030. Topical Administration, one of the segments analyzed in the report, is expected to record a 3.3% ... Read More

  • Adult Stores

    ... at a CAGR of 6.8% over the analysis period 2023-2030. Sex Toys, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$34.6 Billion by the end of ... Read More

  • Prescription Drugs

    ... at a CAGR of 5.7% over the analysis period 2023-2030. Generics, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$498.0 Billion by the end of the ... Read More

  • Oncology Nutrition

    ... at a CAGR of 9.4% over the analysis period 2023-2030. Head & Neck Cancer Nutrition, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$609.6 Million by ... Read More

  • Global Age-Related Macular Degeneration Market Forecast Report by Disease Type (Dry Age-Related Macular Degeneration Market, Wet Age-Related Macular Degeneration Market) Product (Eylea, Lucentis, Beovu, Others) Distribution Channel (Hospital Pharmacy, Specialty Pharma, Online Pharmacy) Countries and Company Analysis, 2024-2032

    ... Company Analysis, 2024-2032 Age-Related Macular Degeneration Market Analysis The Global Age-Related Macular Degeneration market is forecasted to reach US$ 19.53 billion by 2032 from US$ 10.68 billion in 2023, and compound annual growth rate of ... Read More

  • 2024 France Infectious Disease Molecular Diagnostics Market for 100 Tests: Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review

    ... evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. Report Highlights Business and technological trends in major markets Five-year test volume and sales forecasts Market shares of leading competitors ... Read More

  • Orthopedic Veterinary Implants

    ... by 2030, growing at a CAGR of 6.7% over the analysis period 2023-2030. Veterinary Bone Plates, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$86.4 Million ... Read More

  • Asia Pacific Esoteric Testing Market Size study, by Type (Oncology testing, Infectious disease testing, Genetic testing, Endocrinology testing, Toxicology testing, Neurology testing, Others), By Technology (Chemiluminescence immunoassay, Enzyme-linked immunosorbent assay, Mass spectrometry, Real time polymerase chain reaction, Flow cytometry, Other), By End Use (Hospital-based laboratories, Independent and reference laboratories, Others) and Country Forecasts 2022-2032

    ... chain reaction, Flow cytometry, Other), By End Use (Hospital-based laboratories, Independent and reference laboratories, Others) and Country Forecasts 2022-2032 Asia Pacific Esoteric Testing Market is valued approximately at USD 3.53 Billion in 2023 and is ... Read More

  • Renal Denervation Technologies

    ... by 2030, growing at a CAGR of 41.7% over the analysis period 2023-2030. Radiofrequency Based Renal Denervation Technologies, one of the segments analyzed in the report, is expected to record a 41.2% CAGR and reach ... Read More

  • Cancer Therapies

    ... at a CAGR of 10.4% over the analysis period 2023-2030. Chemotherapy, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$112.8 Billion by the end of the ... Read More

  • Carotid Stents

    ... at a CAGR of 8.7% over the analysis period 2023-2030. Balloon Expandable Stents, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$4.3 Billion by the end ... Read More

  • Antibiotics

    ... of 3.1% over the analysis period 2023-2030. Penicillin, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$15.7 Billion by the end of the analysis period. Growth ... Read More

  • Brachytherapy

    ... of 4.4% over the analysis period 2023-2030. High Dose Rate Brachytherapy, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$1.6 Billion by the end of the ... Read More

  • Human Growth Hormone Drugs

    ... reach US$5.2 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2023-2030. Subcutaneous Administration, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach ... Read More

  • Dental Infection Control Products

    ... reach US$2.3 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2023-2030. Dental Infection Control Consumables, one of the segments analyzed in the report, is expected to record a 7.7% CAGR ... Read More

  • Lung Cancer Diagnostics

    ... by 2030, growing at a CAGR of 7.8% over the analysis period 2023-2030. Imaging Tests, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$2.3 Billion by ... Read More

  • Cancer Vaccines

    ... at a CAGR of 9.4% over the analysis period 2023-2030. Preventive Vaccine, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$7.6 Billion by the end of ... Read More

  • CNS Therapeutics

    ... at a CAGR of 7.2% over the analysis period 2023-2030. Neurodegenerative Diseases Therapeutics, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$75.9 Billion by the end ... Read More

  • Clear Aligners

    ... at a CAGR of 23.7% over the analysis period 2023-2030. Clear Aligners for Adults, one of the segments analyzed in the report, is expected to record a 20.4% CAGR and reach US$14.9 Billion by the ... Read More

  • Colorectal Cancer Therapeutics

    ... by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$14.9 Billion by ... Read More

  • Bladder Cancer Therapeutics

    ... by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030. Transitional Cell Bladder Cancer Therapeutics, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach ... Read More

  • Chronic Obstructive Pulmonary Disease (COPD) Treatment

    ... the year 2023, is expected to reach US$27.8 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Combination Drugs, one of the segments analyzed in the report, is expected to ... Read More

  • Medical Exoskeleton Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Body Part Covered

    ... the forecast period 2024-2035. Medical exoskeletons, wearable robotic devices tailored to aid individuals with mobility impairments, harness a blend of mechanical, electronic, and computer-controlled systems to bolster and refine the user's movement. Typically, homing in ... Read More

Cookie Settings